Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-17

Clinical Trial Update: Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren's Syndrome [Phase 3]

View source ↗

Summary

This update notes the completion of a Phase 3 trial evaluating hydroxychloroquine for dry eyes in patients with primary Sjögren's syndrome; results are not prov…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Autoimmune Diseases, Sjogren's Syndrome | Phase 3 | Status: COMPLETED